News

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...
An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...
By Dennis Thompson HealthDay ReporterTUESDAY, June 24, 2025 (HealthDay News) — A new Chinese-developed GLP-1 weight loss drug could prove a new competitor to blockbuster drugs Ozempic /Wegovy and ...
A new study finds combining bimagrumab with Wegovy leads to significant fat loss without muscle loss. This breakthrough ...
Eli Lilly & Company (NYSE:LLY) is one of billionaire Stan Druckenmiller’s top stock picks with huge upside potential.
What Percentage of African Americans Have Diabetes? The American Diabetes Association or ADA reported that the percentage of non-Hispanic African Americans with diabetes was 11.7 percent. That's ...
The endocrinologist and researcher was one of several investigators who presented Phase 3 clinical trial results at the 85th Scientific Sessions of the American Diabetes Association for a long-lasting ...
Semaglutide improved time spent in glycemic range, time below rate and reduced body weight with low rates of hypoglycemia ...
I paired my Oura ring with Dexcom's Stelo AI-powered CGM to track my glucose. Here's what I learned about my eating habits.
Amgen's long-acting experimental obesity drug MariTide needs to be given at a low starting dose to limit side effects like ...
For adults with obesity or overweight without diabetes, the novel cyclic adenosine monophosphate-biased glucagon-like peptide ...
CHICAGO -- Mifepristone (Korlym) reduced HbA1c levels in patients with inadequately controlled type 2 diabetes and ...